DAIVOBET

This brand name is authorized in Austria, Australia, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Israel, Lithuania, Malta, Mexico, Nigeria, New Zealand, Poland, Romania, Singapore, Tunisia

Active ingredients

The drug DAIVOBET contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcipotriol UNII 143NQ3779B - CALCIPOTRIENE

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing. Read about Calcipotriol

2 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DAIVOBET Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX52	Calcipotriol, combinations	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10075G, 9494Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541112080000504, 541112090000603, 541112090000803, 541112090000903
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28331-12-07, 360140512
Country: EE	Ravimiamet	Identifier(s): 1093328, 1093339, 1093340, 1093351, 1093362, 1093373, 1534610, 1534621, 1534632, 1534643, 1616161, 1717242, 1717253
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64543, 70191
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 009810, 009843, 041516, 047114, 088705, 088714, 505807
Country: FR	Base de données publique des médicaments	Identifier(s): 63931033, 68414260
Country: HK	Department of Health Drug Office	Identifier(s): 50661
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-414888118
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4703, 4704
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004143, 1010200, 1010201, 1061376, 1064028, 1064029, 1064030, 1065083, 1065084, 1065085, 1071357, 1074468, 1074469, 1079253, 1079254, 1080566
Country: MT	Medicines Authority	Identifier(s): MA024/00501
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 116M2012, 341M2004
Country: NG	Registered Drug Product Database	Identifier(s): B4-8503
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11528, 14789
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100201534, 100272327, 100386380
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56194001, W56194002, W56194003, W56194004, W56194005, W58498001, W58498002, W58498003, W58498004, W58498005, W58498006, W58498007, W58498008, W58498009
Country: SG	Health Sciences Authority	Identifier(s): 12241P, 14318P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5823064, 5823065, 5823066